Literature DB >> 25576370

Social feeding in Caenorhabditis elegans is modulated by antipsychotic drugs and calmodulin and may serve as a protophenotype for asociality.

Donard S Dwyer1, Poonam Awatramani2, Rashmi Thakur2, Ramya Seeni3, Eric J Aamodt4.   

Abstract

Here, we define a protophenotype as an endophenotype that has been conserved during evolution. Social feeding in Caenorhabditis elegans may be an example of a protophenotype related to asociality in schizophrenia. It is regulated by the highly conserved neuropeptide Y receptor, NPR-1, and we speculated that social feeding should be affected by antipsychotic drugs. The social feeding strain, npr-1(g320), was exposed to antipsychotic drugs, dopamine or calmodulin antagonists on plates with bacterial lawns, and the number of aggregates on the plates was counted as a measure of social feeding. First-generation antipsychotics, chlorpromazine, trifluoperazine, fluphenazine, and haloperidol, and the second-generation drug, olanzapine, inhibited social feeding. Dopamine accelerated aggregation, whereas selective D2 dopamine receptor antagonists, sulpiride and raclopride, were inhibitory. Calmodulin antagonists effectively inhibited social feeding, as did RNAi knockdown of calmodulin (cmd-1) expression. In addition, gap junction inhibitors prevented aggregation, which is consistent with the hub-and-spoke arrangement of neurons that regulate social feeding via functional gap junctions. The studies described here revealed novel connections between dopaminergic signaling, the NPY receptor, calmodulin, and gap junctions in the regulation of social behavior in C. elegans. These pathways are evolutionarily-conserved, and have also been implicated in the pathogenesis of schizophrenia.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antipsychotic drugs; Asociality; Calmodulin; Dopamine; Endophenotypes; Gap junctions; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 25576370     DOI: 10.1016/j.neuropharm.2014.12.027

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

Review 1.  Crossing the Worm-Brain Barrier by Using Caenorhabditis elegans to Explore Fundamentals of Human Psychiatric Illness.

Authors:  Donard S Dwyer
Journal:  Mol Neuropsychiatry       Date:  2018-01-11

2.  Insulin Signaling Deficiency Produces Immobility in Caenorhabditis elegans That Models Diminished Motivation States in Man and Responds to Antidepressants.

Authors:  Julie Dagenhardt; Angeline Trinh; Halen Sumner; Jeffrey Scott; Eric Aamodt; Donard S Dwyer
Journal:  Mol Neuropsychiatry       Date:  2017-09-21

3.  Loss of the Schizophrenia-linked Furin protein from Drosophila mushroom body neurons results in antipsychotic-reversible habituation deficits.

Authors:  Kyriaki Foka; Eirini-Maria Georganta; Ourania Semelidou; Efthimios M C Skoulakis
Journal:  J Neurosci       Date:  2022-08-25       Impact factor: 6.709

Review 4.  Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery.

Authors:  Jason Henry; Donald Wlodkowic
Journal:  Mar Drugs       Date:  2019-06-06       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.